The role of HM13 expression and its relationship to PI3K/Akt and p53 signaling pathways in colorectal cancer
Authors:
- 27 December 2024
- journal article
- research article
- Published by Elsevier in Tissue and Cell
- Vol. 93, 102702
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis‐Targeting Chimeras Enhanced ImmunotherapyAdvanced Materials, 2023
- Histocompatibility Minor 13 (HM13), targeted by miR-760, exerts oncogenic role in breast cancer by suppressing autophagy and activating PI3K-AKT-mTOR pathwayCell Death & Disease, 2022
- Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancerCell Death & Differentiation, 2022
- Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significanceSeminars in Cancer Biology, 2019
- Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradationOncogene, 2018
- miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83DBiomedicine & Pharmacotherapy, 2017
- Honokiol induces autophagic cell death in malignant glioma through reactive oxygen species-mediated regulation of the p53/PI3K/Akt/mTOR signaling pathwayToxicology and Applied Pharmacology, 2016
- Mallory–Denk bodies form when EZH2/H3K27me3 fails to methylate DNA in the nuclei of human and mice liver cellsExperimental and Molecular Pathology, 2012
- Tail-anchored membrane proteins: exploring the complex diversity of tail-anchored-protein targeting in plant cellsPlant Cell Reports, 2010
- Requirements for Signal Peptide Peptidase-Catalyzed Intramembrane ProteolysisMolecular Cell, 2002